Vismodegib free base
To Order Contact us: lieven@wlsolutions.be
Vismodegib |
||
| 20-abx182703 |
|
|
Vismodegib |
||
| HY-10440 | 10mM/1mL | EUR 93.08 |
|
Description: Vismodegib (GDC-0449) is an orally active hedgehog pathway inhibitor with an IC50 of 3 nM. Vismodegib also inhibits P-gp, ABCG2 with IC50 values of 3.0 μM and 1.4 μM, respectively[1][2]. |
||
Vismodegib |
||
| MBS3606376-100mg | 100mg | EUR 220 |
Vismodegib |
||
| MBS3606376-10mg | 10mg | EUR 195 |
Vismodegib |
||
| MBS3606376-200mg | 200mg | EUR 240 |
Vismodegib |
||
| MBS3606376-50mg | 50mg | EUR 210 |
Vismodegib |
||
| MBS3606376-5x200mg | 5x200mg | EUR 760 |
Vismodegib |
||
| MBS808259-25mg | 25mg | EUR 230 |
Vismodegib |
||
| MBS808259-5mg | 5mg | EUR 195 |
Vismodegib |
||
| MBS808259-5x25mg | 5x25mg | EUR 780 |
Vismodegib |
||
| MBS808259-5x5mg | 5x5mg | EUR 615 |
Vismodegib |
||
| SIH-565-25MG | 25 mg | EUR 85.6 |
Vismodegib |
||
| SIH-565-5MG | 5 mg | EUR 49.6 |
Vismodegib |
||
| T2590-10mg | 10mg | Ask for price |
|
Description: Vismodegib |
||
Vismodegib |
||
| T2590-1g | 1g | Ask for price |
|
Description: Vismodegib |
||
Vismodegib |
||
| T2590-1mg | 1mg | Ask for price |
|
Description: Vismodegib |
||
Vismodegib |
||
| T2590-50mg | 50mg | Ask for price |
|
Description: Vismodegib |
||
Vismodegib |
||
| T2590-5mg | 5mg | Ask for price |
|
Description: Vismodegib |
||
Vismodegib |
||
| V674700 | 10mg | EUR 97 |
|
Description: 879085-55-9 |
||
Vismodegib-d4 |
||
| V674702 | 25mg | EUR 3000 |
|
Description: 1450990-33-6 |
||
Vismodegib-d7 |
||
| V674703 | 25mg | EUR 4500 |
GDC-0449 (Vismodegib) |
||
| A3021-10 | 10 mg | EUR 40 |
|
Description: Stem Cell|Hedgehog |
||
GDC-0449 (Vismodegib) |
||
| A3021-200 | 200 mg | EUR 88 |
|
Description: Stem Cell|Hedgehog |
||
GDC-0449 (Vismodegib) |
||
| A3021-5.1 | 10 mM (in 1mL DMSO) | EUR 44 |
|
Description: Stem Cell|Hedgehog |
||
GDC-0449 (Vismodegib) |
||
| A3021-50 | 50 mg | EUR 52 |
|
Description: Stem Cell|Hedgehog |
||
GDC-0449 (Vismodegib) |
||
| A3021-500 | 500 mg | EUR 176 |
|
Description: Stem Cell|Hedgehog |
||
GDC-0449 (Vismodegib) |
||
| A3021-S | Evaluation Sample | EUR 24 |
|
Description: Stem Cell|Hedgehog |
||
Vismodegib (GDC-0449) |
||
| MBS131018-100mg | 100mg | EUR 1065 |
Vismodegib (GDC-0449) |
||
| MBS131018-500mg | 500mg | EUR 2775 |
Vismodegib (GDC-0449) |
||
| MBS576445-100mg | 100mg | EUR 170 |
Vismodegib (GDC-0449) |
||
| MBS576445-10mg | 10mg | EUR 145 |
Vismodegib (GDC-0449) |
||
| MBS576445-200mg | 200mg | EUR 185 |
Vismodegib (GDC-0449) |
||
| MBS576445-50mg | 50mg | EUR 155 |
Vismodegib (GDC-0449) |
||
| MBS576445-5mg | 5mg | EUR 130 |
GDC-0449 (Vismodegib) |
||
| MBS385437-1mLinDMSO | 1mL(inDMSO) | EUR 140 |
GDC-0449 (Vismodegib) |
||
| MBS385437-200mg | 200mg | EUR 200 |
GDC-0449 (Vismodegib) |
||
| MBS385437-25mg | 25mg | EUR 140 |
GDC-0449 (Vismodegib) |
||
| MBS385437-50mg | 50mg | EUR 145 |
GDC-0449 (Vismodegib) |
||
| MBS385437-5x200mg | 5x200mg | EUR 890 |
Vismodegib (GDC-04491) |
||
| 27010 | 25 mg | EUR 90 |
|
Description: Vismodegib (GDC-0449) is a potent hedgehog (Hh) signaling pathway inhibitor. |
||
Vismodegib (GDC-04491) |
||
| 27015 | 50 mg | EUR 125 |
|
Description: Vismodegib (GDC-0449) is a potent hedgehog (Hh) signaling pathway inhibitor. |
||
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-10mg | 10mg | EUR 470 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-1mg | 1mg | EUR 210 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-25mg | 25mg | EUR 780 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-50mg | 50mg | EUR 1130 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-5mg | 5mg | EUR 335 |
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-10mg | 10mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-1g | 1g | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-1mg | 1mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-50mg | 50mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-5mg | 5mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
EDC free base |
||
| GM6988 | 5g | EUR 116.06 |
TMB free base |
||
| TB0954 | 1g | EUR 85.06 |
THZ1 (Free base) |
||
| 9664-25 | each | EUR 1227.6 |
THZ1 (Free base) |
||
| 9664-5 | each | EUR 352.8 |
S107 free base |
||
| 530577 | 100.0mg | EUR 750 |
NG25 free base |
||
| 562503 | 5.0mg | EUR 485 |
FIPI free base |
||
| 407955 | 200.0mg | EUR 1050 |
K201 free base |
||
| 414202 | 5.0mg | EUR 288 |
R406 (free base) |
||
| A5880-100 | 100 mg | EUR 800 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-25 | 25 mg | EUR 320 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-5 | 5 mg | EUR 80 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-5.1 | 10 mM (in 1mL DMSO) | EUR 148 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-S | Evaluation Sample | EUR 24 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
FIPI (free base) |
||
| B2372-25 | each | EUR 757.2 |
FIPI (free base) |
||
| B2372-5 | each | EUR 235.2 |
R406(free base) |
||
| MBS131267-100mg | 100mg | EUR 1065 |
R406(free base) |
||
| MBS131267-500mg | 500mg | EUR 2775 |
SIS3 (free base) |
||
| HY-100444 | 10 mg | EUR 1244.61 |
|
Description: SIS3 free base is a potent and selective inhibitor of Smad3 phosphorylation. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 free base does not affect the phosphorylation of Smad2[1]. |
||
R406 (free base) |
||
| HY-11108 | 10mM/1mL | EUR 465.38 |
|
Description: R406 free base is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 free base reduces immune complex-mediated inflammation[1]. R406 free base also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[2]. |
||
R406(free base) |
||
| E1KS1533 | 2mg | EUR 362.4 |
SIS3 free base |
||
| MBS5767611-5mg | 5mg | EUR 915 |
SIS3 free base |
||
| MBS5767611-5x5mg | 5x5mg | EUR 3970 |
R406 free base |
||
| MBS3606124-10mg | 10mg | EUR 305 |
R406 free base |
||
| MBS3606124-25mg | 25mg | EUR 405 |
R406 free base |
||
| MBS3606124-2mg | 2mg | EUR 235 |
R406 free base |
||
| MBS3606124-50mg | 50mg | EUR 620 |
R406 free base |
||
| MBS3606124-5mg | 5mg | EUR 260 |
R788 free base |
||
| MBS3606474-10mg | 10mg | EUR 315 |
R788 free base |
||
| MBS3606474-25mg | 25mg | EUR 430 |
R788 free base |
||
| MBS3606474-2mg | 2mg | EUR 225 |
R788 free base |
||
| MBS3606474-5mg | 5mg | EUR 260 |
R788 free base |
||
| MBS3606474-5x25mg | 5x25mg | EUR 1620 |
R406 (free base) |
||
| MBS8506526-2mg | 2mg | EUR 440 |
R406 (free base) |
||
| MBS8506526-5x2mg | 5x2mg | EUR 1835 |
SIS3 free base |
||
| T12923-10mg | 10mg | Ask for price |
|
Description: SIS3 free base |
||